ESTABLISHMENT OF SORAFENIB-RESISTANT MOUSE RENAL CELL CARCINOMA RENCA CELLS AND CHARACTERIZATION OF THEIR ACQUIRED RESISTANT MECHANISM

被引：0
|
作者：
Kusuda, Yuji
Miyake, Hideaki
Sakai, Iori
Fujisawa, Masato
机构：
来源：
JOURNAL OF UROLOGY | 2012年 / 187卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
299
引用
收藏
页码：E121 / E121
页数：1
相关论文
共 50 条
  • [41] Metformin Resensitizes Sorafenib-Resistant HCC Cells Through AMPK-Dependent Autophagy Activation
    Lai, Hong-Yue
    Tsai, Hsin-Hwa
    Yen, Chia-Jui
    Hung, Liang-Yi
    Yang, Ching-Chieh
    Ho, Chung-Han
    Liang, Hsin-Yin
    Chen, Feng-Wei
    Li, Chien-Feng
    Wang, Ju-Ming
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [42] Novel FLT3/AURK multikinase inhibitor is efficacious against sorafenib-refractory and sorafenib-resistant hepatocellular carcinoma
    You-Liang Lai
    Kai-Hung Wang
    Hsing-Pang Hsieh
    Wan-Ching Yen
    Journal of Biomedical Science, 29
  • [43] Metformin Resensitizes Sorafenib-Resistant HCC Cells Through AMPK-Dependent Autophagy Activation
    Lai, Hong-Yue
    Tsai, Hsin-Hwa
    Yen, Chia-Jui
    Hung, Liang-Yi
    Yang, Ching-Chieh
    Ho, Chung-Han
    Liang, Hsin-Yin
    Chen, Feng-Wei
    Li, Chien-Feng
    Wang, Ju-Ming
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 8
  • [44] Novel FLT3/AURK multikinase inhibitor is efficacious against sorafenib-refractory and sorafenib-resistant hepatocellular carcinoma
    Lai, You-Liang
    Wang, Kai-Hung
    Hsieh, Hsing-Pang
    Yen, Wan-Ching
    JOURNAL OF BIOMEDICAL SCIENCE, 2022, 29 (01)
  • [45] Sorafenib-resistant hepatocellular carcinoma stratified by phosphorylated ERK activates PD-1 immune checkpoint
    Chen, Jiang
    Ji, Tong
    Zhao, Jie
    Li, Gaofeng
    Zhang, Jian
    Jin, Renan
    Liu, Jinghua
    Liu, Xiaolong
    Liang, Xiao
    Huang, Diyu
    Xie, Anyong
    Lin, Hui
    Cang, Yong
    Cai, Xiujun
    ONCOTARGET, 2016, 7 (27) : 41274 - 41284
  • [46] Establishment and characterization of an acquired cisplatin-resistant subline in a human osteosarcoma cell line
    Asada, N
    Tsuchiya, H
    Ueda, Y
    Tomita, K
    ANTICANCER RESEARCH, 1998, 18 (3A) : 1765 - 1768
  • [47] Amentoflavone enhances sorafenib-induced apoptosis through extrinsic and intrinsic pathways in sorafenib-resistant hepatocellular carcinoma SK-Hep1 cells in vitro
    Chen, Wei-Lung
    Hsieh, Chia-Ling
    Chen, Jiann-Hwa
    Huang, Chih-Sheng
    Chen, Wei-Ting
    Kuo, Yu-Cheng
    Chen, Cheng-Yu
    Hsu, Fei-Ting
    ONCOLOGY LETTERS, 2017, 14 (03) : 3229 - 3234
  • [48] Establishment and characterization of a paclitaxel-resistant human esophageal carcinoma cell line
    Wang, Cong
    Guo, Liu-Bin
    Ma, Jun-Yuan
    Li, Yong-Mei
    Liu, Hong-Min
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2013, 43 (05) : 1607 - 1617
  • [49] Everolimus (RAD001) activity in renal and hepatocellular carcinoma cells resistant to sunitinib and sorafenib
    Serova, Maria
    Riveiro, Maria Eugenia
    Dokmak, Safi
    Faivre, Sandrine
    Raymond, Eric
    CANCER RESEARCH, 2011, 71
  • [50] Transcriptomics-Based Drug Repurposing Approach Identifies Novel Drugs against Sorafenib-Resistant Hepatocellular Carcinoma
    Regan-Fendt, Kelly
    Li, Ding
    Reyes, Ryan
    Yu, Lianbo
    Wani, Nissar A.
    Hu, Peng
    Jacob, Samson T.
    Ghoshal, Kalpana
    Payne, Philip R. O.
    Motiwala, Tasneem
    CANCERS, 2020, 12 (10) : 1 - 22
12345